Hardman & Co Report now available for eXroid
- On March 26, 2018
- By GrowthInvest Admin
We are delighted to announce med-tech company eXroid now have a Hardman & Co report available on the eXroid platform proposal. eXroid provide treatments for internal haemorrhoids, having delivered more than 2,500 treatments over 3 1/2 years. They are raising capital to develop their own equipment and to resume their fast-growing treatment business with a backlog of more than 800 patients waiting to be treated in the UK. To date, they have raised £625,000 of their target raise.
To view the Hardman & Co report, simply log in to the platform, navigate to the eXroid proposal linked here and click the ‘DD Report’ button to view.
If you have any questions about the investment opportunity available with eXroid, please do not hesitate to call us on 020 7071 3945, or email us at email@example.com.
GET IN TOUCH!
CALL US020 7071 3945
FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.